» Articles » PMID: 37955756

Stenotrophomonas Maltophilia: An Urgent Threat with Increasing Antibiotic Resistance

Overview
Journal Curr Microbiol
Specialty Microbiology
Date 2023 Nov 13
PMID 37955756
Authors
Affiliations
Soon will be listed here.
Abstract

Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can cause many infections, such as chronic pulmonary infections in patients with cystic fibrosis and infections in immunocompromised patients with hematology-oncology diseases. Because of its remarkable and increasing antimicrobial resistance, the treatment of S. maltophilia infections is quite challenging. Meanwhile, the prevalence of S. maltophilia infections is increasing in recent decades. S. maltophilia is usually considered to be of low virulence but has numerous virulence factors involved in the pathogenesis of infections caused by S. maltophilia. By revealing its pathogenesis associated with virulence factors and molecular mechanisms of antimicrobial resistance, many existing or potential therapeutic strategies have been developed. However, because of the limited treatment options, new strategies are urgently needed. Here, we review the recent progresses in research on S. maltophilia which may help to develop more effective treatments against this increasing threat.

Citing Articles

Persistence of in Patients with Bacteremia: Incidence, Clinical and Microbiologic Characters, and Outcomes.

Kim S, Ji S, Cho D, Lee A, Jeong H, Kim M Microorganisms. 2025; 12(12.

PMID: 39770680 PMC: 11727890. DOI: 10.3390/microorganisms12122477.


Baicalin enhances antioxidant, inflammatory defense, and microbial diversity of yellow catfish () infected with .

Yan P, Liu J, Huang Y, Yi T, Zhang H, Dai G Front Microbiol. 2024; 15:1465346.

PMID: 39372274 PMC: 11449889. DOI: 10.3389/fmicb.2024.1465346.


Bactericidal effectors of the type IV secretion system: functional definition of the nuclease TfdA and structural determination of TfcB.

Cobe B, Dey S, Minasov G, Inniss N, Satchell K, Cianciotto N mBio. 2024; 15(7):e0119824.

PMID: 38832773 PMC: 11253643. DOI: 10.1128/mbio.01198-24.


Human nasal microbiota shifts in healthy and chronic respiratory disease conditions.

Konovalovas A, Armalyte J, Klimkaite L, Liveikis T, Jonaityte B, Danila E BMC Microbiol. 2024; 24(1):150.

PMID: 38678223 PMC: 11055347. DOI: 10.1186/s12866-024-03294-5.


HemU and TonB1 contribute to hemin acquisition in .

Liao C, Lu H, Yang C, Yeh T, Lin Y, Yang T Front Cell Infect Microbiol. 2024; 14:1380976.

PMID: 38596648 PMC: 11002078. DOI: 10.3389/fcimb.2024.1380976.

References
1.
Barsky E, Williams K, Priebe G, Sawicki G . Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis. Pediatr Pulmonol. 2017; 52(10):1276-1282. DOI: 10.1002/ppul.23781. View

2.
Menetrey Q, Sorlin P, Jumas-Bilak E, Chiron R, Dupont C, Marchandin H . and : Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung. Genes (Basel). 2021; 12(5). PMC: 8142972. DOI: 10.3390/genes12050610. View

3.
Barbolla R, Catalano M, Orman B, Famiglietti A, Vay C, Smayevsky J . Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother. 2004; 48(2):666-9. PMC: 321565. DOI: 10.1128/AAC.48.2.666-669.2004. View

4.
Biagi M, Lamm D, Meyer K, Vialichka A, Jurkovic M, Patel S . Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2020; 64(12). PMC: 7674038. DOI: 10.1128/AAC.00297-20. View

5.
Brooke J . Advances in the Microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev. 2021; 34(3):e0003019. PMC: 8262804. DOI: 10.1128/CMR.00030-19. View